Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Iovance Biotherapeutics Inc (NASDAQ: IOVA) closed at $13.29M up 11248017% from its previous closing price of $2.04. In other words, the price has increased by $11248017 from its previous closing price. On the day, 11.25 million shares were traded. IOVA stock price reached its highest trading level at $2.088 during the session, while it also had its lowest trading level at $1.97.
Ratios:
For a deeper understanding of Iovance Biotherapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 05 ’25 when Kirby Daniel Gordon bought 30,000 shares for $1.84 per share. The transaction valued at 55,200 led to the insider holds 30,000 shares of the business.
Puri Raj K. bought 5,600 shares of IOVA for $9,743 on May 23 ’25. The Chief Regulatory Officer now owns 206,852 shares after completing the transaction at $1.74 per share. On May 14 ’25, another insider, Vogt Frederick G, who serves as the Interim CEO & General Counsel of the company, bought 25,000 shares for $1.69 each. As a result, the insider paid 42,250 and bolstered with 374,646 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOVA now has a Market Capitalization of 661189376 and an Enterprise Value of 355198080. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.11 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at 1.67 whereas that against EBITDA is -0.973.
Stock Price History:
The Beta on a monthly basis for IOVA is 0.86, which has changed by -0.75735295 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, IOVA has reached a high of $12.51, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -20.60%, while the 200-Day Moving Average is calculated to be -68.16%.
Shares Statistics:
For the past three months, IOVA has traded an average of 13.29M shares per day and 13950460 over the past ten days. A total of 333.93M shares are outstanding, with a floating share count of 271.49M. Insiders hold about 18.70% of the company’s shares, while institutions hold 64.00% stake in the company. Shares short for IOVA as of 1748563200 were 86361273 with a Short Ratio of 6.50, compared to 1745971200 on 74567033. Therefore, it implies a Short% of Shares Outstanding of 86361273 and a Short% of Float of 28.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
